{"id": "article-25640_0", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Continuing Education Activity", "content": "Meningococcal\u00a0disease is an infection caused by the bacterium Neisseria meningitidis .\u00a0Meningococcal infections affect individuals of all ages, including healthy\u00a0young adults. N meningitidis  is the leading cause of bacterial meningitis in children and young adults, and the second-leading cause of community-acquired bacterial meningitis\u00a0in adults. Although meningitis and meningococcemia are the classical presentations of meningococcal disease, a broad spectrum of clinical manifestations exists, spanning\u00a0from asymptomatic nasopharyngeal colonization to fulminant disease. Prompt identification of patients with meningococcal disease,\u00a0initiation of treatment, and prophylaxis for their close contacts\u00a0are critical because meningococcal disease can rapidly progress and cause severe complications or death.", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Continuing Education Activity. Meningococcal\u00a0disease is an infection caused by the bacterium Neisseria meningitidis .\u00a0Meningococcal infections affect individuals of all ages, including healthy\u00a0young adults. N meningitidis  is the leading cause of bacterial meningitis in children and young adults, and the second-leading cause of community-acquired bacterial meningitis\u00a0in adults. Although meningitis and meningococcemia are the classical presentations of meningococcal disease, a broad spectrum of clinical manifestations exists, spanning\u00a0from asymptomatic nasopharyngeal colonization to fulminant disease. Prompt identification of patients with meningococcal disease,\u00a0initiation of treatment, and prophylaxis for their close contacts\u00a0are critical because meningococcal disease can rapidly progress and cause severe complications or death."}
{"id": "article-25640_1", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Continuing Education Activity", "content": "This educational activity reviews the etiology and epidemiology of N meningitidis infection. The need for a thorough history and clinical evaluation to develop\u00a0tailored\u00a0treatment strategies for patients with N meningitidis infection. This course highlights the\u00a0need for\u00a0interprofessional team collaboration\u00a0to improve the management of meningococcal disease and patient outcomes.", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Continuing Education Activity. This educational activity reviews the etiology and epidemiology of N meningitidis infection. The need for a thorough history and clinical evaluation to develop\u00a0tailored\u00a0treatment strategies for patients with N meningitidis infection. This course highlights the\u00a0need for\u00a0interprofessional team collaboration\u00a0to improve the management of meningococcal disease and patient outcomes."}
{"id": "article-25640_2", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Continuing Education Activity", "content": "Objectives: Identify\u00a0the clinical manifestations of Neisseria meningitidis infection. Apply evidence-based diagnostic strategies\u00a0for patients suspected\u00a0of having Neisseria meningitidis infection. Implement timely and appropriate\u00a0treatment strategies for patients with Neisseria meningitidis infection. Collaborate with interprofessional team\u00a0members to improve the care coordination of those with Neisseria meningitidis infection, improving patient outcomes. Access free multiple choice questions on this topic.", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Continuing Education Activity. Objectives: Identify\u00a0the clinical manifestations of Neisseria meningitidis infection. Apply evidence-based diagnostic strategies\u00a0for patients suspected\u00a0of having Neisseria meningitidis infection. Implement timely and appropriate\u00a0treatment strategies for patients with Neisseria meningitidis infection. Collaborate with interprofessional team\u00a0members to improve the care coordination of those with Neisseria meningitidis infection, improving patient outcomes. Access free multiple choice questions on this topic."}
{"id": "article-25640_3", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Introduction", "content": "Neisseria meningitidis was first discovered by Anton Weichselbaum  in 1887  during his analysis of the cerebrospinal fluid (CSF)\u00a0from a patient infected with meningitis. [1] N meningitidis is a human-specific bacterium that causes a multitude of illnesses, collectively termed as meningococcal disease. Up to 10% of the general population carries the bacteria in their nose and throat without experiencing any adverse effects.\u00a0Risk factors for meningococcal carriage include being in the\u00a0adolescent and young adult age group, being male, living in congregate conditions, being exposed to cigarette smoke, and frequently\u00a0attending bars and parties. [2]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Introduction. Neisseria meningitidis was first discovered by Anton Weichselbaum  in 1887  during his analysis of the cerebrospinal fluid (CSF)\u00a0from a patient infected with meningitis. [1] N meningitidis is a human-specific bacterium that causes a multitude of illnesses, collectively termed as meningococcal disease. Up to 10% of the general population carries the bacteria in their nose and throat without experiencing any adverse effects.\u00a0Risk factors for meningococcal carriage include being in the\u00a0adolescent and young adult age group, being male, living in congregate conditions, being exposed to cigarette smoke, and frequently\u00a0attending bars and parties. [2]"}
{"id": "article-25640_4", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Introduction", "content": "N meningitidis is associated with many infections. However, its association with fulminant meningococcemia and meningococcal meningitis has led to its significant impact. More importantly, despite recent vaccine campaigns to help reduce complications of this disease, its effects continue to impact at-risk populations. [3]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Introduction. N meningitidis is associated with many infections. However, its association with fulminant meningococcemia and meningococcal meningitis has led to its significant impact. More importantly, despite recent vaccine campaigns to help reduce complications of this disease, its effects continue to impact at-risk populations. [3]"}
{"id": "article-25640_5", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Etiology", "content": "N meningitidis is an aerobic or facultative anaerobic, gram-negative diplococcus that exclusively infects humans (see Image. Diplococci). [4] There are at least 12 serotypes based on unique capsular polysaccharides of N meningitidis , with serotypes A, B, C, W, X, and Y responsible for\u00a0the majority of meningococcal infections. Serotypes A and C are the main serotypes responsible for meningococcal disease in Africa. Serotypes B, C, and Y are the main serotypes causing disease in Europe, the United States, and Canada. [5] Serotype W is responsible for epidemic outbreaks\u00a0worldwide and is associated\u00a0with the Hajj pilgrimages\u00a0to Saudi Arabia. [6]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Etiology. N meningitidis is an aerobic or facultative anaerobic, gram-negative diplococcus that exclusively infects humans (see Image. Diplococci). [4] There are at least 12 serotypes based on unique capsular polysaccharides of N meningitidis , with serotypes A, B, C, W, X, and Y responsible for\u00a0the majority of meningococcal infections. Serotypes A and C are the main serotypes responsible for meningococcal disease in Africa. Serotypes B, C, and Y are the main serotypes causing disease in Europe, the United States, and Canada. [5] Serotype W is responsible for epidemic outbreaks\u00a0worldwide and is associated\u00a0with the Hajj pilgrimages\u00a0to Saudi Arabia. [6]"}
{"id": "article-25640_6", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Etiology", "content": "N meningitidis is a common and significant cause of community-acquired bacterial meningitis in the United States,\u00a0affecting children and adults. It is a devastating infection with a high mortality rate\u00a0and is the second most common cause of community-acquired adult bacterial meningitis after Streptococcus\u00a0pneumoniae . [7]  Other infections that N meningitidis can cause are meningococcemia (a bloodstream infection\u00a0caused by the bacterium), pneumonia, septic arthritis, pericarditis, and urethritis. In addition, N meningitidis can also cause endemic and epidemic infections, affecting young, healthy adults. [5]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Etiology. N meningitidis is a common and significant cause of community-acquired bacterial meningitis in the United States,\u00a0affecting children and adults. It is a devastating infection with a high mortality rate\u00a0and is the second most common cause of community-acquired adult bacterial meningitis after Streptococcus\u00a0pneumoniae . [7]  Other infections that N meningitidis can cause are meningococcemia (a bloodstream infection\u00a0caused by the bacterium), pneumonia, septic arthritis, pericarditis, and urethritis. In addition, N meningitidis can also cause endemic and epidemic infections, affecting young, healthy adults. [5]"}
{"id": "article-25640_7", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Epidemiology", "content": "The incidence of meningococcal disease has decreased  with the routine administration of meningococcal vaccination.\u00a0In the United States, the\u00a0incidence of meningococcal disease decreased\u00a0from 1.2 cases per 100,000 individuals in 1996 to 0.1 cases per 100,000 individuals in 2018. [5] The highest incidence of meningococcal disease appears in infants younger than 1 (2.45 cases per 100,000 individuals). [8] N meningitidis can cause endemic and epidemic outbreaks\u00a0and is a significant cause of bacterial meningitis in sub-Saharan Africa, leading to the region being\u00a0called the  meningitis belt. [5] The mortality rate\u00a0varies from approximately 10%\u00a0to 14% among patients who receive treatment and can reach up to 50% among patients who do not receive treatment. [9]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Epidemiology. The incidence of meningococcal disease has decreased  with the routine administration of meningococcal vaccination.\u00a0In the United States, the\u00a0incidence of meningococcal disease decreased\u00a0from 1.2 cases per 100,000 individuals in 1996 to 0.1 cases per 100,000 individuals in 2018. [5] The highest incidence of meningococcal disease appears in infants younger than 1 (2.45 cases per 100,000 individuals). [8] N meningitidis can cause endemic and epidemic outbreaks\u00a0and is a significant cause of bacterial meningitis in sub-Saharan Africa, leading to the region being\u00a0called the  meningitis belt. [5] The mortality rate\u00a0varies from approximately 10%\u00a0to 14% among patients who receive treatment and can reach up to 50% among patients who do not receive treatment. [9]"}
{"id": "article-25640_8", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pathophysiology", "content": "Humans are the exclusive hosts of Neisseria meningitidis , carrying the pathogen in their nasopharynx before the onset of systemic infection.\u00a0Colonized humans may be asymptomatic carriers. [2] Colonization of the nasopharynx\u00a0puts individuals who are in close contact with infected patients, such as family members, college roommates, and military recruits, at an increased risk of contracting N meningitidis and possible infection. Individuals\u00a0involved in laboratory work or medical care exposure, such as intubating an infected patient with no face shield or mask, are also at an increased risk of N meningitidis colonization of the nasopharynx through inhaling aerosolized particles containing the bacteria. The incubation period varies and ranges from 1 to 14 days. [10]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pathophysiology. Humans are the exclusive hosts of Neisseria meningitidis , carrying the pathogen in their nasopharynx before the onset of systemic infection.\u00a0Colonized humans may be asymptomatic carriers. [2] Colonization of the nasopharynx\u00a0puts individuals who are in close contact with infected patients, such as family members, college roommates, and military recruits, at an increased risk of contracting N meningitidis and possible infection. Individuals\u00a0involved in laboratory work or medical care exposure, such as intubating an infected patient with no face shield or mask, are also at an increased risk of N meningitidis colonization of the nasopharynx through inhaling aerosolized particles containing the bacteria. The incubation period varies and ranges from 1 to 14 days. [10]"}
{"id": "article-25640_9", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pathophysiology", "content": "Once N meningitidis is colonized, several virulence factors help the bacterium in invading human cells and the immune system. After  it  invades the bloodstream, a robust immune response is triggered, leading to\u00a0endothelial damage, capillary leakage, tissue necrosis, organ failure, and the development of meningococcal sepsis. Bloodstream invasion is considered to be the primary route\u00a0to the brain, but N meningitidis can also cross the cribriform plate of the ethmoid bone. [11]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pathophysiology. Once N meningitidis is colonized, several virulence factors help the bacterium in invading human cells and the immune system. After  it  invades the bloodstream, a robust immune response is triggered, leading to\u00a0endothelial damage, capillary leakage, tissue necrosis, organ failure, and the development of meningococcal sepsis. Bloodstream invasion is considered to be the primary route\u00a0to the brain, but N meningitidis can also cross the cribriform plate of the ethmoid bone. [11]"}
{"id": "article-25640_10", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pathophysiology", "content": "Similar to\u00a0many other diseases,\u00a0the immune system is essential in protecting the host. Certain health conditions that weaken the human immune system increase the risk of contracting meningococcal diseases, including meningococcemia and meningitis. These conditions\u00a0include HIV infection, AIDS, asplenia, and complement deficiency. [4]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pathophysiology. Similar to\u00a0many other diseases,\u00a0the immune system is essential in protecting the host. Certain health conditions that weaken the human immune system increase the risk of contracting meningococcal diseases, including meningococcemia and meningitis. These conditions\u00a0include HIV infection, AIDS, asplenia, and complement deficiency. [4]"}
{"id": "article-25640_11", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- History and Physical", "content": "The clinical presentation of N meningitidis can vary widely and may initially appear benign, making it difficult to diagnose, especially in areas with no reported epidemics. Typically, the initial presentation of N meningitidis caused by meningitis can include sudden onset of fever, headache, nausea, vomiting, severe myalgias, nonspecific rash, sore throat, and other upper respiratory symptoms. These symptoms\u00a0may be confused with a multitude of other illnesses. The potential for rapid disease progression, especially given the possibility of death within hours of symptom onset, makes early identification of meningococcal disease challenging due to its low incidence and nonspecific early symptoms. Later presentation of the meningococcal disease includes neck stiffness, photophobia, petechiae or hemorrhagic rash, altered mental status, shock, abnormal skin color, purpura fulminans, or even disseminated intravascular coagulation. [10]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- History and Physical. The clinical presentation of N meningitidis can vary widely and may initially appear benign, making it difficult to diagnose, especially in areas with no reported epidemics. Typically, the initial presentation of N meningitidis caused by meningitis can include sudden onset of fever, headache, nausea, vomiting, severe myalgias, nonspecific rash, sore throat, and other upper respiratory symptoms. These symptoms\u00a0may be confused with a multitude of other illnesses. The potential for rapid disease progression, especially given the possibility of death within hours of symptom onset, makes early identification of meningococcal disease challenging due to its low incidence and nonspecific early symptoms. Later presentation of the meningococcal disease includes neck stiffness, photophobia, petechiae or hemorrhagic rash, altered mental status, shock, abnormal skin color, purpura fulminans, or even disseminated intravascular coagulation. [10]"}
{"id": "article-25640_12", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- History and Physical", "content": "Vital signs may include hypotension and tachycardia, which indicate early signs of sepsis. A complete physical examination should be conducted, including a thorough skin inspection for any signs of a\u00a0rash. The rash, a distinguishing feature, may initially appear as small lesions that may appear urticarial, macular, or papular. The rash can develop into petechiae, purpura,\u00a0or ecchymosis later (see Image. Petechiae). These may be early signs of thrombocytopenia, purpura fulminans, and disseminated intravascular coagulation. [10] Although Kernig and Brudzinski signs are classic signs of meningitis, their respective sensitivities of 55.5% and 53.3% make them unreliable in excluding meningitis. [12] When considering signs and symptoms of the disease, it is important to note that the classic triad of fever, altered mental status, and nuchal rigidity is rare, occurring in only about 44% of cases. However, when 2 of the 4 symptoms, including headache, altered mental status, neck stiffness, and fever, were present, 95% of patients ultimately diagnosed with meningitis were identified. [13] Clinicians should consider N meningitidis infection in patients with sudden onset of fever who display early signs of sepsis, rapidly progressing disease, and rash.", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- History and Physical. Vital signs may include hypotension and tachycardia, which indicate early signs of sepsis. A complete physical examination should be conducted, including a thorough skin inspection for any signs of a\u00a0rash. The rash, a distinguishing feature, may initially appear as small lesions that may appear urticarial, macular, or papular. The rash can develop into petechiae, purpura,\u00a0or ecchymosis later (see Image. Petechiae). These may be early signs of thrombocytopenia, purpura fulminans, and disseminated intravascular coagulation. [10] Although Kernig and Brudzinski signs are classic signs of meningitis, their respective sensitivities of 55.5% and 53.3% make them unreliable in excluding meningitis. [12] When considering signs and symptoms of the disease, it is important to note that the classic triad of fever, altered mental status, and nuchal rigidity is rare, occurring in only about 44% of cases. However, when 2 of the 4 symptoms, including headache, altered mental status, neck stiffness, and fever, were present, 95% of patients ultimately diagnosed with meningitis were identified. [13] Clinicians should consider N meningitidis infection in patients with sudden onset of fever who display early signs of sepsis, rapidly progressing disease, and rash."}
{"id": "article-25640_13", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- History and Physical", "content": "Purpura fulminans, a complication of meningococcal disease resulting from\u00a0vascular collapse, is characterized by cutaneous hemorrhage and skin necrosis due to vascular thrombosis and disseminated intravascular coagulation.\u00a0Typically, petechiae and erythema are\u00a0observed on the skin but can progress to ecchymosis and eventually painful areas of necrosis, with the development of bullae and vesicles. Gangrenous necrosis can occur and be severe, often requiring limb amputation. Atypical skin color, cold hands and feet, and painful legs may be the signs of vascular compromise. [10] Although these infections are rarely\u00a0caused by N meningitidis , meningococcal disease\u00a0can also include\u00a0pneumonia, septic arthritis, urethritis, and pericarditis. [5]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- History and Physical. Purpura fulminans, a complication of meningococcal disease resulting from\u00a0vascular collapse, is characterized by cutaneous hemorrhage and skin necrosis due to vascular thrombosis and disseminated intravascular coagulation.\u00a0Typically, petechiae and erythema are\u00a0observed on the skin but can progress to ecchymosis and eventually painful areas of necrosis, with the development of bullae and vesicles. Gangrenous necrosis can occur and be severe, often requiring limb amputation. Atypical skin color, cold hands and feet, and painful legs may be the signs of vascular compromise. [10] Although these infections are rarely\u00a0caused by N meningitidis , meningococcal disease\u00a0can also include\u00a0pneumonia, septic arthritis, urethritis, and pericarditis. [5]"}
{"id": "article-25640_14", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Evaluation", "content": "A lumbar puncture is the preferred diagnostic tool for identifying meningitis. Prioritizing a lumbar puncture ensures prompt evaluation and diagnosis.\u00a0Evidence of elevated intracranial pressure,\u00a0such as\u00a0altered mental status, new-onset seizure within\u00a01 week of symptoms, papilledema, an immunocompromised state, or focal neurologic deficits; coagulopathy; and cardiorespiratory insufficiency are contraindications to lumbar puncture. Antibiotic administration should occur promptly, even before lumbar puncture completion, for those patients when meningitis is highly likely to be\u00a0the diagnosis. [9] Even in pretreated patients, blood cultures and CSF studies can still be useful. CSF analysis should include gram staining, culture, glucose, cell count, and protein count. CSF findings that suggest bacterial meningitis include decreased  glucose levels, polymorphonuclear pleocytosis, and increased protein levels. CSF culture is the gold standard for the diagnosis of bacterial meningitis. [14]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Evaluation. A lumbar puncture is the preferred diagnostic tool for identifying meningitis. Prioritizing a lumbar puncture ensures prompt evaluation and diagnosis.\u00a0Evidence of elevated intracranial pressure,\u00a0such as\u00a0altered mental status, new-onset seizure within\u00a01 week of symptoms, papilledema, an immunocompromised state, or focal neurologic deficits; coagulopathy; and cardiorespiratory insufficiency are contraindications to lumbar puncture. Antibiotic administration should occur promptly, even before lumbar puncture completion, for those patients when meningitis is highly likely to be\u00a0the diagnosis. [9] Even in pretreated patients, blood cultures and CSF studies can still be useful. CSF analysis should include gram staining, culture, glucose, cell count, and protein count. CSF findings that suggest bacterial meningitis include decreased  glucose levels, polymorphonuclear pleocytosis, and increased protein levels. CSF culture is the gold standard for the diagnosis of bacterial meningitis. [14]"}
{"id": "article-25640_15", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Evaluation", "content": "CSF gram staining,\u00a0polymerase chain reaction (PCR), and latex agglutination may aid in confirmation, particularly in patients with negative CSF cultures after antibiotic pretreatment. PCR detects strands of bacterial DNA, not requiring an intact bacterium for detection, whereas latex agglutination detects capsular antigens. [14]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Evaluation. CSF gram staining,\u00a0polymerase chain reaction (PCR), and latex agglutination may aid in confirmation, particularly in patients with negative CSF cultures after antibiotic pretreatment. PCR detects strands of bacterial DNA, not requiring an intact bacterium for detection, whereas latex agglutination detects capsular antigens. [14]"}
{"id": "article-25640_16", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Evaluation", "content": "Computed tomography (CT) imaging may assist in the diagnosis of patients with altered mental status, mainly to rule out other diagnoses under consideration. [9] If imaging is necessary, it is crucial to coordinate with the nursing team and imaging suite to avoid delaying antibiotic administration.", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Evaluation. Computed tomography (CT) imaging may assist in the diagnosis of patients with altered mental status, mainly to rule out other diagnoses under consideration. [9] If imaging is necessary, it is crucial to coordinate with the nursing team and imaging suite to avoid delaying antibiotic administration."}
{"id": "article-25640_17", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management", "content": "Early recognition and treatment of meningococcal infections are imperative in improving outcomes. The primary focus in treating meningococcal infection includes administering\u00a0antibiotics, implementing isolation, contact precaution, consulting with infectious disease specialists, management in the intensive care unit (ICU), management of coagulopathies, and identifying individuals at risk who may have been exposed to N meningitidis . [9]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management. Early recognition and treatment of meningococcal infections are imperative in improving outcomes. The primary focus in treating meningococcal infection includes administering\u00a0antibiotics, implementing isolation, contact precaution, consulting with infectious disease specialists, management in the intensive care unit (ICU), management of coagulopathies, and identifying individuals at risk who may have been exposed to N meningitidis . [9]"}
{"id": "article-25640_18", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management", "content": "Because meningococcal meningitis can present similarly to other bacterial meningitides, empiric treatment should be\u00a0initiated while awaiting culture results. This preemptive approach includes a third-generation cephalosporin such as ceftriaxone or cefotaxime. If culture identifies the organism as penicillin-susceptible, treatment can be switched to penicillin G. However, continuing third-generation cephalosporin treatment is also an option. For patients who have significant allergies to penicillin and other beta-lactams, chloramphenicol may be an alternative. The duration of antibiotic therapy is\u00a0typically\u00a05\u00a0to\u00a06 days. [9] [15]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management. Because meningococcal meningitis can present similarly to other bacterial meningitides, empiric treatment should be\u00a0initiated while awaiting culture results. This preemptive approach includes a third-generation cephalosporin such as ceftriaxone or cefotaxime. If culture identifies the organism as penicillin-susceptible, treatment can be switched to penicillin G. However, continuing third-generation cephalosporin treatment is also an option. For patients who have significant allergies to penicillin and other beta-lactams, chloramphenicol may be an alternative. The duration of antibiotic therapy is\u00a0typically\u00a05\u00a0to\u00a06 days. [9] [15]"}
{"id": "article-25640_19", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management -- Dosages", "content": "Ceftriaxone\u00a0dosing is 2 g for adults and 50 mg/kg\u00a0for pediatric patients older than 1 month given intravenously (IV) every 12 hours, whereas\u00a0cefotaxime dosing is 2 g every 4\u00a0to 6 hours for adults\u00a0and 50 mg/kg\u00a0for pediatric patients older than 1 month every 6 hours. [9] Third-generation cephalosporins are generally preferable due to their high efficacy and simpler\u00a0dosing regimens. Penicillin G dosing is 4 million units every 4 hours IV\u00a0for\u00a0adults and pediatric patients older than 1 month. [9] Chloramphenicol dosing is 50 mg/kg IV 4 times per day. [9] Serum concentrations require monitoring because of the risk of chloramphenicol toxicity. [16]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management -- Dosages. Ceftriaxone\u00a0dosing is 2 g for adults and 50 mg/kg\u00a0for pediatric patients older than 1 month given intravenously (IV) every 12 hours, whereas\u00a0cefotaxime dosing is 2 g every 4\u00a0to 6 hours for adults\u00a0and 50 mg/kg\u00a0for pediatric patients older than 1 month every 6 hours. [9] Third-generation cephalosporins are generally preferable due to their high efficacy and simpler\u00a0dosing regimens. Penicillin G dosing is 4 million units every 4 hours IV\u00a0for\u00a0adults and pediatric patients older than 1 month. [9] Chloramphenicol dosing is 50 mg/kg IV 4 times per day. [9] Serum concentrations require monitoring because of the risk of chloramphenicol toxicity. [16]"}
{"id": "article-25640_20", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management", "content": "High-dose dexamethasone should be administered at initial suspicion of bacterial meningitis due to its protective benefits in pneumococcal meningitis. [9] [17] Dexamethasone should be administered IV within 4 hours before but no more than 12 hours after the first dose of IV antibiotics. The dosage should be 0.15 mg/kg every 6 hours up to a maximum dosage of 10 mg every 6 hours. [9] [15] However, dexamethasone has no therapeutic benefit in meningococcal meningitis and should be discontinued once this diagnosis is established. [17] [15]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management. High-dose dexamethasone should be administered at initial suspicion of bacterial meningitis due to its protective benefits in pneumococcal meningitis. [9] [17] Dexamethasone should be administered IV within 4 hours before but no more than 12 hours after the first dose of IV antibiotics. The dosage should be 0.15 mg/kg every 6 hours up to a maximum dosage of 10 mg every 6 hours. [9] [15] However, dexamethasone has no therapeutic benefit in meningococcal meningitis and should be discontinued once this diagnosis is established. [17] [15]"}
{"id": "article-25640_21", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management", "content": "Patients with meningococcal infection should also be treated aggressively with supportive care, especially for sepsis or septic shock. This may include intravenous fluid resuscitation and the use of vasopressors such as norepinephrine. [15] Patients who show evidence of disseminated intravascular coagulation may require aggressive hydration, blood transfusions, platelet replacement, and possibly even coagulation factor replacement. Researchers have proposed protein C as an adjuvant treatment, but its use is controversial and currently not commonly used. [9]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Treatment / Management. Patients with meningococcal infection should also be treated aggressively with supportive care, especially for sepsis or septic shock. This may include intravenous fluid resuscitation and the use of vasopressors such as norepinephrine. [15] Patients who show evidence of disseminated intravascular coagulation may require aggressive hydration, blood transfusions, platelet replacement, and possibly even coagulation factor replacement. Researchers have proposed protein C as an adjuvant treatment, but its use is controversial and currently not commonly used. [9]"}
{"id": "article-25640_22", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Differential Diagnosis", "content": "S pneumoniae is the most common cause of bacterial meningitis in the United States and should be included in the differential diagnosis for patients suspected of having meningococcal meningitis. Less common causes of bacterial meningitis include Haemophilus influenzae ,\u00a0group B Streptococcus , and Listeria monocytogenes . [14] Other causes of meningitis include viral, tuberculous, eosinophilic, and fungal meningitis and noninfectious causes such as malignancy. [18]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Differential Diagnosis. S pneumoniae is the most common cause of bacterial meningitis in the United States and should be included in the differential diagnosis for patients suspected of having meningococcal meningitis. Less common causes of bacterial meningitis include Haemophilus influenzae ,\u00a0group B Streptococcus , and Listeria monocytogenes . [14] Other causes of meningitis include viral, tuberculous, eosinophilic, and fungal meningitis and noninfectious causes such as malignancy. [18]"}
{"id": "article-25640_23", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Differential Diagnosis", "content": "Clinicians examining adults with a maculopapular rash and fever should consider alternate etiologies, including\u00a0infectious mononucleosis, West Nile virus, Zika virus, HIV, Ebola virus, Rocky Mountain spotted fever, ehrlichiosis, and hypersensitivity drug reactions. [19] In addition, children with a maculopapular rash and fever should be considered for a differential diagnosis that includes Kawasaki disease, measles, scarlet fever, rubella, parvovirus B19, roseola,\u00a0Epstein-Barr virus, and hand, foot, and mouth disease. [20]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Differential Diagnosis. Clinicians examining adults with a maculopapular rash and fever should consider alternate etiologies, including\u00a0infectious mononucleosis, West Nile virus, Zika virus, HIV, Ebola virus, Rocky Mountain spotted fever, ehrlichiosis, and hypersensitivity drug reactions. [19] In addition, children with a maculopapular rash and fever should be considered for a differential diagnosis that includes Kawasaki disease, measles, scarlet fever, rubella, parvovirus B19, roseola,\u00a0Epstein-Barr virus, and hand, foot, and mouth disease. [20]"}
{"id": "article-25640_24", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Prognosis", "content": "Although\u00a0the mortality rate of meningococcal infection can be as high as 50% in untreated patients, early and aggressive treatment can reduce the mortality rate to approximately 10%\u00a0to 14%. Early administration of antibiotics is\u00a0crucial\u00a0in determining a good outcome of meningococcal infection. Even with treatment, long-term complications can still occur in 11%\u00a0to 19% of survivors. [9]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Prognosis. Although\u00a0the mortality rate of meningococcal infection can be as high as 50% in untreated patients, early and aggressive treatment can reduce the mortality rate to approximately 10%\u00a0to 14%. Early administration of antibiotics is\u00a0crucial\u00a0in determining a good outcome of meningococcal infection. Even with treatment, long-term complications can still occur in 11%\u00a0to 19% of survivors. [9]"}
{"id": "article-25640_25", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Prognosis", "content": "Similar to other causes of bacterial meningitis, patients who survive meningococcal infections should undergo routine follow-up. Hearing tests are recommended within\u00a04 weeks of hospital discharge.\u00a0Orthopedic follow-up and prosthetic fitting are necessary for patients who have suffered limb amputations. Patients may experience psychological and psychiatric complications, including posttraumatic stress disorder, depression, and behavioral abnormalities, requiring follow-up with psychologists\u00a0and psychiatrists. [15]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Prognosis. Similar to other causes of bacterial meningitis, patients who survive meningococcal infections should undergo routine follow-up. Hearing tests are recommended within\u00a04 weeks of hospital discharge.\u00a0Orthopedic follow-up and prosthetic fitting are necessary for patients who have suffered limb amputations. Patients may experience psychological and psychiatric complications, including posttraumatic stress disorder, depression, and behavioral abnormalities, requiring follow-up with psychologists\u00a0and psychiatrists. [15]"}
{"id": "article-25640_26", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Complications", "content": "Common complications of meningococcal disease include chronic pain, skin scarring, limb amputation, and neurological impairments,\u00a0ranging from hearing and visual impairments to motor function impairments. Hearing impairment and amputations occur in approximately 3% of cases, arthritis occurs in 10% of cases, and postinfection inflammatory syndrome occurs in 6% to 15% of cases. Up to one-third of survivors of meningococcal disease experience psychological disorders such as posttraumatic stress disorder, anxiety, and depression. [9] Urgent complications of meningococcal disease include septic shock,\u00a0purpura fulminans,\u00a0seizures,\u00a0hydrocephalus, cerebral venous sinus thrombosis, and subdural empyema. [15]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Complications. Common complications of meningococcal disease include chronic pain, skin scarring, limb amputation, and neurological impairments,\u00a0ranging from hearing and visual impairments to motor function impairments. Hearing impairment and amputations occur in approximately 3% of cases, arthritis occurs in 10% of cases, and postinfection inflammatory syndrome occurs in 6% to 15% of cases. Up to one-third of survivors of meningococcal disease experience psychological disorders such as posttraumatic stress disorder, anxiety, and depression. [9] Urgent complications of meningococcal disease include septic shock,\u00a0purpura fulminans,\u00a0seizures,\u00a0hydrocephalus, cerebral venous sinus thrombosis, and subdural empyema. [15]"}
{"id": "article-25640_27", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Consultations", "content": "The interprofessional team managing meningococcal infection consists of internists, pediatricians, infectious disease specialists, hematologists, neurologists, and nursing staff. [15]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Consultations. The interprofessional team managing meningococcal infection consists of internists, pediatricians, infectious disease specialists, hematologists, neurologists, and nursing staff. [15]"}
{"id": "article-25640_28", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Deterrence and Patient Education", "content": "Early recognition and treatment of those infected are crucial, as meningococcal infection is a devastating infectious disease that has led to\u00a0epidemics in the past and can do so again. Any meningococcal infection is reportable, and local health departments should be notified. [5]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Deterrence and Patient Education. Early recognition and treatment of those infected are crucial, as meningococcal infection is a devastating infectious disease that has led to\u00a0epidemics in the past and can do so again. Any meningococcal infection is reportable, and local health departments should be notified. [5]"}
{"id": "article-25640_29", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Deterrence and Patient Education", "content": "Vaccination\u00a0is the best strategy for preventing meningococcal disease, especially in populations at higher risk. The infectious disease nurse should educate patients about vaccination. Vaccines against N meningitidis serogroups A, C, W, Y, and B are routinely recommended in the United States for adolescents, young adults, and\u00a0individuals at increased risk for meningococcal disease. The overall burden of meningococcal infection worldwide has diminished due to these vaccinations. [5]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Deterrence and Patient Education. Vaccination\u00a0is the best strategy for preventing meningococcal disease, especially in populations at higher risk. The infectious disease nurse should educate patients about vaccination. Vaccines against N meningitidis serogroups A, C, W, Y, and B are routinely recommended in the United States for adolescents, young adults, and\u00a0individuals at increased risk for meningococcal disease. The overall burden of meningococcal infection worldwide has diminished due to these vaccinations. [5]"}
{"id": "article-25640_30", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Deterrence and Patient Education", "content": "Individuals at risk, including college students, military recruits, immunocompromised patients such as those with HIV/AIDS, complement deficiency, and those with asplenia, should be vaccinated. Individuals\u00a0who work with N meningitidis in laboratories, travelers to endemic areas such as the meningitis belt, and those\u00a0exposed to outbreaks of meningococcal vaccine should also be vaccinated based on local epidemiology. [5]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Deterrence and Patient Education. Individuals at risk, including college students, military recruits, immunocompromised patients such as those with HIV/AIDS, complement deficiency, and those with asplenia, should be vaccinated. Individuals\u00a0who work with N meningitidis in laboratories, travelers to endemic areas such as the meningitis belt, and those\u00a0exposed to outbreaks of meningococcal vaccine should also be vaccinated based on local epidemiology. [5]"}
{"id": "article-25640_31", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Deterrence and Patient Education", "content": "*Although the Advisory Committee on Immunization Practices (ACIP) recommends routine MenACWY vaccination only for individuals aged 11 through 18, MenACWY may be given to individuals aged 19 through 21 if they have not been vaccinated previously. Moreover, the MenACWY vaccine is mandatory for all individuals visiting Mecca for Hajj/Umrah. [5]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Deterrence and Patient Education. *Although the Advisory Committee on Immunization Practices (ACIP) recommends routine MenACWY vaccination only for individuals aged 11 through 18, MenACWY may be given to individuals aged 19 through 21 if they have not been vaccinated previously. Moreover, the MenACWY vaccine is mandatory for all individuals visiting Mecca for Hajj/Umrah. [5]"}
{"id": "article-25640_32", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pearls and Other Issues", "content": "Individuals who come into close contact with meningococcal-infected patients can themselves become infected and display symptoms within\u00a014 days after initial contact. Close contact refers to proximity\u00a0with the patient for more than\u00a04 hours within the past 7 days. Examples\u00a0of close contacts include family members, roommates, military recruits, and individuals in daycare centers. [10] Individuals\u00a0who are exposed to the patient's oral secretions, such as through kissing, or respiratory secretions, such as during intubation, suctioning, and\u00a0proximity with\u00a0passengers on a long flight, are also at risk. If recognized, antimicrobial chemoprophylaxis should be initiated. Due to its high efficacy, chemoprophylaxis should be strongly considered\u00a0for patients who may have had questionable close contact with an infected patient. Several antimicrobial chemoprophylaxis options are listed below. [9]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pearls and Other Issues. Individuals who come into close contact with meningococcal-infected patients can themselves become infected and display symptoms within\u00a014 days after initial contact. Close contact refers to proximity\u00a0with the patient for more than\u00a04 hours within the past 7 days. Examples\u00a0of close contacts include family members, roommates, military recruits, and individuals in daycare centers. [10] Individuals\u00a0who are exposed to the patient's oral secretions, such as through kissing, or respiratory secretions, such as during intubation, suctioning, and\u00a0proximity with\u00a0passengers on a long flight, are also at risk. If recognized, antimicrobial chemoprophylaxis should be initiated. Due to its high efficacy, chemoprophylaxis should be strongly considered\u00a0for patients who may have had questionable close contact with an infected patient. Several antimicrobial chemoprophylaxis options are listed below. [9]"}
{"id": "article-25640_33", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pearls and Other Issues", "content": "Ceftriaxone\u00a0is administered at 250 mg intramuscularly as a one-time dose for adults and 125 mg for pediatric patients younger than 15. Rifampin is prescribed at 600 mg orally or intravenously twice daily for 2 days for adults. In pediatric patients younger than 1 month, the recommended dosage is 5 mg/kg, whereas for those older than 1 month, it is 10 mg/kg. Rifampin is not recommended for pregnant patients. Ciprofloxacin is given orally at 500 mg as a one-time dose for adults, and for pediatric patients older than 1 month, the dosage is 20 mg/kg (maximum 500 mg). Azithromycin,\u00a0typically reserved as a last choice, is administered orally at 500 mg as a one-time dose in adults\u00a0and 10 mg/kg (maximum 500 mg) in pediatric patients older than 1 month.", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Pearls and Other Issues. Ceftriaxone\u00a0is administered at 250 mg intramuscularly as a one-time dose for adults and 125 mg for pediatric patients younger than 15. Rifampin is prescribed at 600 mg orally or intravenously twice daily for 2 days for adults. In pediatric patients younger than 1 month, the recommended dosage is 5 mg/kg, whereas for those older than 1 month, it is 10 mg/kg. Rifampin is not recommended for pregnant patients. Ciprofloxacin is given orally at 500 mg as a one-time dose for adults, and for pediatric patients older than 1 month, the dosage is 20 mg/kg (maximum 500 mg). Azithromycin,\u00a0typically reserved as a last choice, is administered orally at 500 mg as a one-time dose in adults\u00a0and 10 mg/kg (maximum 500 mg) in pediatric patients older than 1 month."}
{"id": "article-25640_34", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Enhancing Healthcare Team Outcomes", "content": "Meningococcal infection is a devastating, contagious disease that can progress rapidly. Recognizing the illness is perhaps the most challenging part of assessing and treating patients. This requires an interprofessional team consisting of physicians, infectious disease specialists, ICU nurses, pharmacists, adherence to proper isolation protocols, and collaboration with the local health department to treat infected patients. Meningococcal disease is reportable, and the local health department can assist in identifying individuals at risk and managing\u00a0outbreaks. [5]", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Enhancing Healthcare Team Outcomes. Meningococcal infection is a devastating, contagious disease that can progress rapidly. Recognizing the illness is perhaps the most challenging part of assessing and treating patients. This requires an interprofessional team consisting of physicians, infectious disease specialists, ICU nurses, pharmacists, adherence to proper isolation protocols, and collaboration with the local health department to treat infected patients. Meningococcal disease is reportable, and the local health department can assist in identifying individuals at risk and managing\u00a0outbreaks. [5]"}
{"id": "article-25640_35", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Enhancing Healthcare Team Outcomes", "content": "Clinicians who initiate treatment would benefit by enlisting the assistance of an infectious disease board-certified pharmacist. They can verify agent selection with the latest antibiogram data,\u00a0confirm dosage, and check for drug interactions that may compromise therapy. Nurses typically administer these agents and should have a comprehensive understanding of appropriate isolation protocols. They also monitor for therapeutic effectiveness and watch for any adverse reactions,\u00a0promptly notifying the healthcare team of any issues. The interprofessional team approach is the best way to optimize therapeutic results while minimizing the spread of infection and adverse reactions.", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Enhancing Healthcare Team Outcomes. Clinicians who initiate treatment would benefit by enlisting the assistance of an infectious disease board-certified pharmacist. They can verify agent selection with the latest antibiogram data,\u00a0confirm dosage, and check for drug interactions that may compromise therapy. Nurses typically administer these agents and should have a comprehensive understanding of appropriate isolation protocols. They also monitor for therapeutic effectiveness and watch for any adverse reactions,\u00a0promptly notifying the healthcare team of any issues. The interprofessional team approach is the best way to optimize therapeutic results while minimizing the spread of infection and adverse reactions."}
{"id": "article-25640_36", "title": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Meningococcal Disease (Neisseria meningitidis Infection)  -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}